Marino

Context: pharmacare is moving, but the next step is disputed

Canada’s national pharmacare effort is at a decision point. Federal material explains the current direction and the first-phase focus on covered categories (including contraception and diabetes medications, with coverage delivered through agreements with provinces and territories). In parallel, recent Canadian political coverage highlights a public disagreement about what should happen next: critics say the federal government has not been clear about whether it intends to keep expanding pharmaca

This proposal is designed to capture that live debate and convert it into a structured civic decision: should Canada push for faster expansion, pause to renegotiate how deals are funded and structured, or keep pharmacare limited until provinces sign on under current terms?

Policy direction: what should Ottawa prioritize next on pharmacare expansion and deal-making?

Public process: when should public forums be held to gather evidence and views?

Access: where should forums be hosted to maximize participation across regions?

Use comments to add additional recent reporting, provincial statements, and documented stakeholder positions. Keep claims tied to sources and distinguish evidence from personal experience.

Public proposals about drug coverage

Search and filter proposals

Public proposals tagged drug coverage

Canada pharmacare next step: expand now or renegotiate first?